Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Difamilast Ointment 1% in Atopic Dermatitis
NCT05608343Phase 3Completed
- Sponsor
- Acrotech Biopharma Inc
- Start
- Oct 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of difamilast in atopic dermatitis (AD), sponsored by Acrotech Biopharma Inc. Started Oct 2022; status: completed.
02
Drugs
difamilast
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT05608343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05608343.